Literature DB >> 27935234

Analysis of antioxidative factors related to AMD risk development in the polish patients.

Malgorzata Mrowicka1, Jerzy Mrowicki1, Jacek Pawel Szaflik2, Marta Szaflik3, Magdalena Ulinska2, Jerzy Szaflik2, Ireneusz Majsterek1.   

Abstract

PURPOSE: Age-related macular degeneration (AMD) is a major cause of blindness in developed countries. Oxidative mechanisms may play a key role in the aetiology of AMD. The main aim of this study was to investigate antioxidative markers in the pathogenesis of AMD.
METHODS: A total of 510 subjects including 240 patients with AMD (mean age 77.9 ± 8.5 year) and 270 controls (mean age 74.0 ± 10.4 year) were allowed in this study. We measured activity of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) and examined their association with the SNPs of respective genes (SOD1 + 35A/C, CAT C-262T and GPx Pro197Leu). Restriction fragment length polymorphism (RFLP) technique was used to determine the selected gene polymorphisms. Sixty subjects including 30 patients with AMD (mean age 69.4 ± 9.3) and 30 controls (mean age 64.6 ± 8.2) were enrolled to determine the activity of antioxidant enzymes by spectrometry method.
RESULTS: A significant decrease in enzymes, SOD (p = 0.011), CAT (p = 0.002) and GPx (p ≤ 0.001) in AMD patients compared to controls, was indicated. The risk of susceptibility to AMD was significantly higher in patients with AMD who had Pro197Leu C/T genotype of GPx (OR = 2.78; 95% CI = 1.78-4.35). The A/C genotype and the C allele frequencies of A/C polymorphism of SOD1 gene significantly reduce the risk of AMD (OR=0.48; 95% CI 0.27; 0.85).
CONCLUSION: In conclusion, our data showed that insufficient antioxidant capacity may have an important role in age-related macular degeneration. The polymorphism of GPx Pro197Leu may reduce the ability to scavenge free radicals in retina and contribute to the development of AMD.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  age-related macular degeneration; antioxidant enzyme; genetic polymorphism; the polish population

Mesh:

Substances:

Year:  2016        PMID: 27935234     DOI: 10.1111/aos.13289

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  6 in total

1.  Deficiency of type 2 iodothyronine deiodinase reduces necroptosis activity and oxidative stress responses in retinas of Leber congenital amaurosis model mice.

Authors:  Fan Yang; Hongwei Ma; Michael R Butler; Xi-Qin Ding
Journal:  FASEB J       Date:  2018-06-06       Impact factor: 5.191

Review 2.  Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases.

Authors:  Ming Yang; Yanling Wang
Journal:  J Ophthalmol       Date:  2022-05-20       Impact factor: 1.974

3.  Enhanced Detection of Sub-Retinal Pigment Epithelial Cell Layer Deposits in Human and Murine Tissue: Imaging Zinc as a Biomarker for Age-Related Macular Degeneration (An American Ophthalmological Society Thesis).

Authors:  Frederik J G M van Kuijk; Scott W McPherson; Heidi Roehrich
Journal:  Trans Am Ophthalmol Soc       Date:  2017-08-22

4.  Novel Possible Protein Targets in Neovascular Age-Related Macular Degeneration: A Pilot Study Experiment.

Authors:  Bruno Nobre Lins Coronado; Felipe Bruno Santos da Cunha; Raphaela Menezes de Oliveira; Otávio de Toledo Nóbrega; Carlos André Ornelas Ricart; Wagner Fontes; Marcelo Valle de Sousa; Marcos Pereira de Ávila; Aline Maria Araújo Martins
Journal:  Front Med (Lausanne)       Date:  2022-01-27

Review 5.  The Pathomechanism, Antioxidant Biomarkers, and Treatment of Oxidative Stress-Related Eye Diseases.

Authors:  Yi-Jen Hsueh; Yen-Ning Chen; Yu-Ting Tsao; Chao-Min Cheng; Wei-Chi Wu; Hung-Chi Chen
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

6.  Prophylactic Instillation of Hydrogen-Rich Water Decreases Corneal Inflammation and Promotes Wound Healing by Activating Antioxidant Activity in a Rat Alkali Burn Model.

Authors:  Momoko Kasamatsu; Takeshi Arima; Toyo Ikebukuro; Yuji Nakano; Yutaro Tobita; Masaaki Uchiyama; Akira Shimizu; Hiroshi Takahashi
Journal:  Int J Mol Sci       Date:  2022-08-29       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.